FSHB and ovarian carcinoma: In addition, liver retention was reduced 2.3 times compared with that of the assembly strategy by using 980 nm laser irradiation, yielding a higher bioimaging SBR of ∼15 and reducing biological toxicity.[283] Moreover, the time interval between the first injection of DCNPs‐L1‐FSHβ and the second injection of complementary nanoprobe DCNPs‐L2‐FSHβ (second) was rationally designed for micro‐ovarian cancer (≤ 1 mm) resection.